New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
07:51 EDTJASO, UNH, NQ, FCEL, PL, BHPOptions expected to be active
News For PL;BHP;NQ;JASO;FCEL;UNH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 19, 2015
09:16 EDTUNHUnitedHealth falls on FY15 guidance
Subscribe for More Information
07:46 EDTUNHOptions expected to be active; UNH AET ANTM CI WCG HUM HNT CNC
Subscribe for More Information
06:40 EDTUNHUnitedHealth volatility flat into lowering FY15 guidance
Subscribe for More Information
06:40 EDTBHPBHP Billiton backs dividend policy amid profit slump, CNBC reports
BHP Billiton (BHP) defended its dividend policy amid a drop in share prices and profits slump this year as well as weak China growth and a recent mine disaster in Brazil, CNBC reports. BHP chairman Jacques Nasser said at the company's annual meeting that the dividend policy is the result of "appropriate capital management," the report says. In addition, the company said it and joint venture partner Vale (VALE) will be commissioning an external probe of the Samarco dam spill, the report says. Reference Link
06:11 EDTUNHUnitedHealth to host conference call
Subscribe for More Information
05:59 EDTUNHUnitedHealth cuts FY15 to $6.00 from $6.25-$6.35
Subscribe for More Information
05:57 EDTUNHUnitedHealth sees FY16 EPS $7.10-$7.30, consensus $7.28
Subscribe for More Information
November 18, 2015
15:40 EDTUNHCongressman says U.S. may need look at pharmacy competition, dealReporter says
Subscribe for More Information
06:58 EDTNQNQ Mobile enters into binding agreement to sell Beijing Tianya
NQ Mobile announced it has entered into a legally binding agreement to sell 100% of the equity interest in Beijing Tianya , which operates NQ Mobile's mobile health applications related business, to Tack Fiori International Group, a Cayman Islands company listed in Hong Kong, for an aggregate consideration of $40M. Beijing Tianya is a wholly owned subsidiary of Beijing NQ Technology Co., Ltd., NQ Mobile's consolidated affiliated entity in China. The company's board has approved both the transaction and the Agreement. The closing of the transaction is subject to the condition that Tack Fiori obtains the necessary approvals, including shareholder approval, to complete the transaction, as well as additional customary closing conditions, and the satisfaction and compliance of all relevant requirements under the Rules Governing the Listing of Securities on the Hong Kong Stock Exchange Limited.
November 17, 2015
10:00 EDTBHPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
09:15 EDTBHPBHP Billiton downgraded to Neutral from Buy at Clarksons Platou
Subscribe for More Information
09:12 EDTFCELUIL Holdings finalizes deal with Woodbridge
Subscribe for More Information
09:05 EDTUNHOptumRx acquires AxelaCare
Subscribe for More Information
08:03 EDTJASOSolar module makers outlook positive, says Bernstein
Subscribe for More Information
07:04 EDTJASOJA Solar reports Q3 EPS 68c, may not compare to consensus 32c
Subscribe for More Information
06:17 EDTBHPBHP Billiton reviewing all dams worldwide, U.K. Times reports
BHP Billiton (BHP) CEO Andrew Mackenzie told analysts and investors at the company's annual general meeting that the company is reviewing all of its dams worldwide after the Samarco mudslide in Brazil killed at least nine people, The U.K. Times reports. Mackenzie also said BHP is considering moving away from the arrangement under which mines that it partly owns are managed by committee rather than by a single operator; the Samarco mine is half run by BHP, with the remainder owned by Vale (VALE). Reference Link
November 16, 2015
18:50 EDTBHPSamarco to set aside $262M for initial costs after Brazil dam breach, WSJ says
Samarco, a joint venture of Vale (VALE) and BHP Billiton (BHP), reached an agreement with Brazilian prosecutors to establish an initial $262M cleanup fund related to two dam breaches at its iron-ore mines in Minas Gerais state, reports the Wall Street Journal. Reference Link
13:26 EDTBHPVale: It will take 'years' for Rio Doce river to recover, Reuters reports
Subscribe for More Information
09:06 EDTUNHDiplomat seen as compelling amid specialty pharmacy fallout
Shares of specialty pharmacy operator Diplomat Pharmacy (DPLO) and pharmacy benefit manager Express Scripts (ESRX) have each been knocked down by the negative news surrounding the sector amid the troubles faced by Valeant (VRX) and others, but an analyst at Leerink contends in a note to investors that the pullbacks in both stocks provide buying opportunities. BACKGROUND: Drugmaker Valeant and its prior specialty pharmacy partner, Philidor Rx Services, have been at the center of the firestorm engulfing the sector. Following claims that Philidor urged its employees to modify prescriptions to ensure more orders of Valeant-branded drugs rather than generics, as well as other allegations of wrongdoing, Express Scripts (ESRX) and peer CVS Health (CVS) terminated Philidor from their networks. The day after those termination announcements, Valeant said that it was severing all ties with Philidor and that the pharmacy planned to shut down operations as soon as possible, consistent with applicable laws. Valeant has subsequently said that Philidor has committed to cease operations by January 30, 2016, at the latest. More recently, Express Scripts, the nation's largest pharmacy benefit manager, announced that it stopped doing business with Linden Care, accusing it of being a "captive" pharmacy that dispenses mostly products made by Horizon Pharma (HZNP). In turn, Horizon called the idea that Linden Care is a captive pharmacy "entirely false," stating that "at best Express Scripts is being reckless in its allegations and at worse it is intentionally attempting to mislead investors." Express Scripts' move also impacted shares of Insys Therapeutics (INSY), which reportedly also used Linden Care to fulfill prescription for its drugs. DIPLOMAT LIKELY TO STAY IN-NETWORK: Leerink analyst David Larsen acknowledged that recent events indicate that Express Scripts appears to be evaluating certain retail pharmacies and their relationships with manufacturers, but he believes Diplomat's mix of drugs for diseases like multiple sclerosis, HIV, hepatitis C and cancer differentiate it as a "true" specialty pharmacy. Larsen does not think Diplomat is at risk of being excluded from the pharmacy networks of Express Scripts, CVS or UnitedHealth's (UNH) Optum, he tells investors. Larsen expects limited distribution agreements to stay an important channel strategy for drugmakers and believes these agreements are appropriate for high cost specialty drugs that require special handling and additional services to manage patient adherence. The analyst, who thinks Diplomat remains well positioned to deliver annual growth of over 30% in the next several years, keeps an Outperform rating on its shares. EXPRESS BUYING OPPORTUNITY: Larsen also thinks concerns around manufacturer and pharmacy relationships have put unwarranted pressure on shares of Express Scripts. He does not expect Express Scripts to disclose new lawsuits around rebate dollars owed over other manufacturer disputes and keeps an Outperform rating on the stock, which he views as having an "attractive" valuation. WHAT'S NOTABLE: Larsen also thinks that the specialty channel remains an opportunity for Walgreens Boots Alliance (WBA) and believes its proposed acquisition of Rite Aid (RAD) can strengthen its specialty offering. The analyst keeps an Outperform rating on Walgreens shares as well. PRICE ACTION: Over the last three months, Diplomat Pharmacy shares have declined 28%, Express Scripts has fallen 6% and Walgreens has dropped 14%.
06:01 EDTBHPBHP Billiton to face questions about Samarco at annual meeting, WSJ reports
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use